Skip to content

Clinical trials

Withdrawn Prostatic Hyperplasia trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Prostatic Hyperplasia Status: Withdrawn Clear all

21 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20082
20112
20132
20152
20161
20172
20182
20191
20213
20221
20231
20251
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Withdrawn21

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Andrew Picel1
Antonios Likourezos1
Apsen Farmaceutica S.A.1
Baylor Research Institute1
Case Comprehensive Cancer Center1
Complexo Hospitalario Universitario de A Coruña1
Elsan1
Fondation Hôpital Saint-Joseph1
Group of Research in Minimally Invasive Techniques1
HistoSonics, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Prostatic Hyperplasia21
Lower Urinary Tract Symptoms3
Prostatic Neoplasms3
Erectile Dysfunction2
Hyperplasia1
Metabolic Syndrome1
Nocturia1
Prostatism1
Urinary Bladder, Overactive1
Urinary Incontinence1

Trials

Showing 26 to 21 of 21. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.